Related Experiment Video
Updated: May 21, 2025
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
Synthesis, anticancer activity and molecular docking study of triphenylphosphonium-linked derivatives of oleanolic
Deshang Li1, Bo Wang1, Rui Wang2
1Marine College, Shandong University, Weihai, China.
Abstract:
Lung cancer and breast cancer both are extremely threatening to humans, so it is needed to develop safe and effective drugs for the treatment of these two ailments. To improve the activity and selectivity of bioactive natural product oleanolic acid (OA), triphenylphosphonium moieties were introduced at different sites of the OA core skeleton. The in vitro antiproliferative activity screening results displayed that the anticancer activity of all target compounds was significantly improved, and some derivatives displayed strong selectivity for breast cancer cells (MCF-7) and lung cancer cells (A549) over the human normal liver cells (QSG-7701 cells). Compounds 6a (for A549 cells) and 5g (for MCF-7 cells) demonstrated the best selectivity (with SI of 12.18 and 7.72, respectively). The docking results showed that 5g and 6c could bind to and interact with PI3K protein through hydrogen bonds and intermolecular hydrophobic forces. These compounds are potential anti-MCF-7 agents and deserve further study.
Insights
Researchers modified oleanolic acid (OA) to create novel anticancer drugs. Derivatives showed improved activity and selectivity against lung and breast cancer cells, offering potential new treatments.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Natural Products
Background:
- Lung and breast cancers pose significant global health threats.
- Developing effective and selective anticancer agents is a critical medical need.
- Oleanolic acid (OA), a natural product, shows promise but requires optimization for therapeutic use.
Purpose of the Study:
- To enhance the antiproliferative activity and selectivity of oleanolic acid (OA).
- To synthesize novel OA derivatives incorporating triphenylphosphonium moieties.
- To evaluate the anticancer potential of these derivatives against lung (A549) and breast (MCF-7) cancer cells.
Main Methods:
- Chemical synthesis of novel oleanolic acid derivatives with triphenylphosphonium groups.
- In vitro antiproliferative activity screening against A549, MCF-7, and QSG-7701 cell lines.
- Molecular docking studies to predict interactions with target proteins like PI3K.
Main Results:
- All synthesized OA derivatives exhibited enhanced anticancer activity compared to the parent compound.
- Compounds 6a and 5g demonstrated significant selectivity for lung (A549) and breast (MCF-7) cancer cells, respectively.
- Docking analysis suggested that derivatives 5g and 6c interact with PI3K protein via hydrogen bonds and hydrophobic forces.
Conclusions:
- Novel oleanolic acid derivatives with triphenylphosphonium moieties show potent and selective anticancer activity.
- Compounds 5g and 6a represent promising candidates for further development as targeted therapies for breast and lung cancer.
- The observed interactions with PI3K protein warrant further investigation into the mechanism of action.
